Published in Lancet Infect Dis on June 26, 2012
Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ (2013) 2.73
Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study. PLoS Med (2013) 2.07
Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982-2012: A Systematic Analysis. PLoS Med (2016) 1.48
Severe Acute Respiratory Illness Deaths in Sub-Saharan Africa and the Role of Influenza: A Case Series From 8 Countries. J Infect Dis (2015) 1.43
A single amino acid in the stalk region of the H1N1pdm influenza virus HA protein affects viral fusion, stability and infectivity. PLoS Pathog (2014) 1.29
Traditional and new influenza vaccines. Clin Microbiol Rev (2013) 1.22
Case fatality risk of influenza A (H1N1pdm09): a systematic review. Epidemiology (2013) 1.21
Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of Disease. Infect Immun (2015) 1.17
Were equatorial regions less affected by the 2009 influenza pandemic? The Brazilian experience. PLoS One (2012) 1.17
The burden of influenza and RSV among inpatients and outpatients in rural western Kenya, 2009-2012. PLoS One (2014) 1.16
Regional variation in mortality impact of the 2009 A(H1N1) influenza pandemic in China. Influenza Other Respir Viruses (2013) 1.15
2009 pandemic H1N1 influenza virus elicits similar clinical course but differential host transcriptional response in mouse, macaque, and swine infection models. BMC Genomics (2012) 1.13
Global mortality of 2009 pandemic influenza A H1N1. Lancet Infect Dis (2012) 1.07
Cryptococcus gattii VGIII isolates causing infections in HIV/AIDS patients in Southern California: identification of the local environmental source as arboreal. PLoS Pathog (2014) 1.07
Extracorporeal life support in critically ill adults. Am J Respir Crit Care Med (2014) 1.06
DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation during influenza A virus infection: role of DDX21-TRIF-TLR4-MyD88 pathway. PLoS Pathog (2014) 1.05
Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study. Am J Respir Crit Care Med (2015) 1.04
Rapidly produced SAM(®) vaccine against H7N9 influenza is immunogenic in mice. Emerg Microbes Infect (2013) 1.04
Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets. PLoS Pathog (2013) 1.04
Reply to "Studies on influenza virus transmission between ferrets: the public health risks revisited". MBio (2015) 1.03
Use of electronic death certificates for influenza death surveillance. Emerg Infect Dis (2014) 1.01
Asparagine substitution at PB2 residue 701 enhances the replication, pathogenicity, and transmission of the 2009 pandemic H1N1 influenza A virus. PLoS One (2013) 1.01
Improvements in pandemic preparedness in 8 Central American countries, 2008-2012. BMC Health Serv Res (2014) 0.99
Burden of influenza-associated deaths in the Americas, 2002-2008. Influenza Other Respir Viruses (2015) 0.98
The 2009 influenza pandemic. Lancet Infect Dis (2013) 0.97
HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection. Proc Natl Acad Sci U S A (2013) 0.96
The 2009 influenza pandemic. Lancet Infect Dis (2013) 0.95
Predominance of HA-222D/G polymorphism in influenza A(H1N1)pdm09 viruses associated with fatal and severe outcomes recently circulating in Germany. PLoS One (2013) 0.95
After 2015: infectious diseases in a new era of health and development. Philos Trans R Soc Lond B Biol Sci (2014) 0.94
M2e-Based Universal Influenza A Vaccines. Vaccines (Basel) (2015) 0.93
Emergency Physicians' Adherence to Center for Disease Control and Prevention Guidance During the 2009 Influenza A H1N1 Pandemic. West J Emerg Med (2013) 0.92
A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus. Nat Commun (2015) 0.91
Excess mortality impact of two epidemics of pandemic influenza A(H1N1pdm09) virus in Hong Kong. Influenza Other Respir Viruses (2013) 0.89
M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A. PLoS One (2013) 0.89
Epidemiological and virological characteristics of influenza viruses circulating in Cambodia from 2009 to 2011. PLoS One (2014) 0.89
Early host responses of seasonal and pandemic influenza A viruses in primary well-differentiated human lung epithelial cells. PLoS One (2013) 0.89
Naturally occurring mutations in the PA gene are key contributors to increased virulence of pandemic H1N1/09 influenza virus in mice. J Virol (2014) 0.89
Evaluation of Unbiased Next-Generation Sequencing of RNA (RNA-seq) as a Diagnostic Method in Influenza Virus-Positive Respiratory Samples. J Clin Microbiol (2015) 0.89
Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories. BMC Public Health (2013) 0.88
Modeling the impact of air, sea, and land travel restrictions supplemented by other interventions on the emergence of a new influenza pandemic virus. BMC Infect Dis (2012) 0.88
Antibody-Based Strategies to Prevent and Treat Influenza. Front Immunol (2015) 0.88
H7N9 T-cell epitopes that mimic human sequences are less immunogenic and may induce Treg-mediated tolerance. Hum Vaccin Immunother (2015) 0.88
MicroRNA expression profile of mouse lung infected with 2009 pandemic H1N1 influenza virus. PLoS One (2013) 0.88
Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir. PLoS One (2014) 0.88
Emergence of Highly Pathogenic Avian Influenza A(H5N1) Virus PB1-F2 Variants and Their Virulence in BALB/c Mice. J Virol (2015) 0.88
Strain-specific antiviral activity of iminosugars against human influenza A viruses. J Antimicrob Chemother (2014) 0.88
Influenza epidemiology in Italy two years after the 2009-2010 pandemic: need to improve vaccination coverage. Hum Vaccin Immunother (2013) 0.88
One health, multiple challenges: The inter-species transmission of influenza A virus. One Health (2015) 0.87
Mortality, severe acute respiratory infection, and influenza-like illness associated with influenza A(H1N1)pdm09 in Argentina, 2009. PLoS One (2012) 0.87
Do corticosteroids reduce the mortality of influenza A (H1N1) infection? A meta-analysis. Crit Care (2015) 0.87
Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection. Virology (2013) 0.87
Identification of critical residues in the hemagglutinin and neuraminidase of influenza virus H1N1pdm for vaccine virus replication in embryonated chicken eggs. J Virol (2013) 0.87
Influenza mortality in the United States, 2009 pandemic: burden, timing and age distribution. PLoS One (2013) 0.86
Genome sequence of a monoreassortant H1N1 swine influenza virus isolated from a pig in Hungary. J Virol (2012) 0.86
Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury. Cell Res (2013) 0.86
Influenza vaccines and influenza antiviral drugs in Africa: are they available and do guidelines for their use exist? BMC Public Health (2014) 0.86
Influenza virus-induced lung inflammation was modulated by cigarette smoke exposure in mice. PLoS One (2014) 0.86
Mycobacteria inactivation using Engineered Water Nanostructures (EWNS). Nanomedicine (2014) 0.85
Towards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensing. Br J Clin Pharmacol (2013) 0.85
Paper-Based RNA Extraction, in Situ Isothermal Amplification, and Lateral Flow Detection for Low-Cost, Rapid Diagnosis of Influenza A (H1N1) from Clinical Specimens. Anal Chem (2015) 0.84
Severe influenza and S. aureus pneumonia: for whom the bell tolls? Virulence (2013) 0.84
Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis. BMC Infect Dis (2013) 0.83
Influenza H1N1pdm-specific maternal antibodies offer limited protection against wild-type virus replication and influence influenza vaccination in ferrets. Influenza Other Respir Viruses (2014) 0.83
Influenza a virus entry: implications in virulence and future therapeutics. Adv Virol (2013) 0.83
Emerging Influenza Strains in the Last Two Decades: A Threat of a New Pandemic? Vaccines (Basel) (2015) 0.83
Global burden of influenza as a cause of cardiopulmonary morbidity and mortality. Glob Heart (2014) 0.82
Severe influenza A(H1N1)pdm09 infection induces thymic atrophy through activating innate CD8(+)CD44(hi) T cells by upregulating IFN-γ. Cell Death Dis (2014) 0.82
The legacies of SARS - international preparedness and readiness to respond to future threats in the Western Pacific Region. Western Pac Surveill Response J (2013) 0.82
Identification and synthesis of quinolizidines with anti-influenza a virus activity. ACS Med Chem Lett (2014) 0.82
Human H7N9 avian influenza virus infection: a review and pandemic risk assessment. Emerg Microbes Infect (2013) 0.82
A geographic analysis of population density thresholds in the influenza pandemic of 1918-19. Int J Health Geogr (2013) 0.82
Deaths associated with respiratory syncytial and influenza viruses among persons ≥5 years of age in HIV-prevalent area, South Africa, 1998-2009(1). Emerg Infect Dis (2015) 0.82
Spillover of pH1N1 to swine in Cameroon: an investigation of risk factors. BMC Vet Res (2014) 0.82
The cost effectiveness of pandemic influenza interventions: a pandemic severity based analysis. PLoS One (2013) 0.81
Potential recombinant vaccine against influenza A virus based on M2e displayed on nodaviral capsid nanoparticles. Int J Nanomedicine (2015) 0.81
The complex link between influenza and severe sepsis. Virulence (2013) 0.81
The 2015 global production capacity of seasonal and pandemic influenza vaccine. Vaccine (2016) 0.81
Responses to A(H1N1)pdm09 influenza vaccines in participants previously vaccinated with seasonal influenza vaccine: a randomized, observer-blind, controlled study. J Infect Dis (2014) 0.81
Functional balance between the hemagglutinin and neuraminidase of influenza A(H1N1)pdm09 HA D222 variants. PLoS One (2014) 0.81
Influenza vaccines: unmet needs and recent developments. Infect Chemother (2013) 0.81
Mortality attributable to seasonal and pandemic influenza, Australia, 2003 to 2009, using a novel time series smoothing approach. PLoS One (2013) 0.81
Heterogeneous and Dynamic Prevalence of Asymptomatic Influenza Virus Infections. Emerg Infect Dis (2016) 0.80
Virological characterization of influenza H1N1pdm09 in Vietnam, 2010-2013. Influenza Other Respir Viruses (2015) 0.80
A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head. J Virol (2014) 0.80
The administration of intranasal live attenuated influenza vaccine induces changes in the nasal microbiota and nasal epithelium gene expression profiles. Microbiome (2015) 0.80
Age-dependent estimates of the epidemiological impact of pandemic influenza (H1N1-2009) in Japan. Comput Math Methods Med (2013) 0.80
Asthma and the flu: a tricky two-step. Immunol Cell Biol (2014) 0.79
Relative efficacy of AS03-adjuvanted pandemic influenza A(H1N1) vaccine in children: results of a controlled, randomized efficacy trial. J Infect Dis (2014) 0.79
A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness. BMC Infect Dis (2014) 0.79
International flight-related transmission of pandemic influenza A(H1N1)pdm09: an historical cohort study of the first identified cases in the United Kingdom. Influenza Other Respir Viruses (2013) 0.79
Using high-throughput sequencing to leverage surveillance of genetic diversity and oseltamivir resistance: a pilot study during the 2009 influenza A(H1N1) pandemic. PLoS One (2013) 0.79
Potential Impact of Co-Infections and Co-Morbidities Prevalent in Africa on Influenza Severity and Frequency: A Systematic Review. PLoS One (2015) 0.79
Mortality attributable to influenza in England and Wales prior to, during and after the 2009 pandemic. PLoS One (2013) 0.79
Specific Inhibitory Effect of κ-Carrageenan Polysaccharide on Swine Pandemic 2009 H1N1 Influenza Virus. PLoS One (2015) 0.79
Sentinel surveillance of influenza in Burkina Faso: identification of circulating strains during 2010-2012. Influenza Other Respir Viruses (2014) 0.79
Human Dendritic Cell Response Signatures Distinguish 1918, Pandemic, and Seasonal H1N1 Influenza Viruses. J Virol (2015) 0.78
Pathogen population bottlenecks and adaptive landscapes: overcoming the barriers to disease emergence. Proc Biol Sci (2016) 0.78
Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71
Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med (2013) 24.88
Foodborne illness acquired in the United States--major pathogens. Emerg Infect Dis (2011) 24.75
Influenza-associated hospitalizations in the United States. JAMA (2004) 18.23
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet (2013) 14.06
Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med (2008) 13.35
Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med (2004) 11.31
Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ (2005) 11.02
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep (2010) 10.59
Dengue: a continuing global threat. Nat Rev Microbiol (2010) 9.96
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep (2008) 9.02
Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA (2006) 8.06
Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med (2008) 7.79
Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med (2013) 7.52
Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis (2008) 7.48
Effect of handwashing on child health: a randomised controlled trial. Lancet (2005) 7.19
Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med (2011) 7.13
Non-pharmaceutical interventions for pandemic influenza, national and community measures. Emerg Infect Dis (2006) 6.85
Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med (2005) 6.83
Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med (2009) 6.65
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med (2015) 6.04
The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med (2009) 5.86
Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. JAMA (2005) 5.84
Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep (2009) 5.80
Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med (2003) 5.60
Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis (2009) 5.56
Nipah virus encephalitis reemergence, Bangladesh. Emerg Infect Dis (2004) 5.49
Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet (2011) 5.43
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep (2007) 5.32
A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis (2012) 5.24
Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2006) 5.19
Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med (2015) 4.90
Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis (2009) 4.72
Estimating the future number of cases in the Ebola epidemic--Liberia and Sierra Leone, 2014-2015. MMWR Surveill Summ (2014) 4.53
Multi-country analysis of the effects of diarrhoea on childhood stunting. Int J Epidemiol (2008) 4.46
Non-pharmaceutical interventions for pandemic influenza, international measures. Emerg Infect Dis (2006) 4.34
Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA (2010) 4.31
Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet (2008) 4.17
Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med (2007) 4.16
Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med (2011) 4.02
Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. Influenza Other Respir Viruses (2009) 4.02
Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. Lancet (2013) 3.98
Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004. Emerg Infect Dis (2006) 3.96
Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet (2013) 3.77
Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis (2005) 3.72
Strengthening standardised interpretation of verbal autopsy data: the new InterVA-4 tool. Glob Health Action (2012) 3.68
Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis (2006) 3.66
Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep (2008) 3.58
Measles in Europe: an epidemiological assessment. Lancet (2009) 3.49
Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis (2007) 3.47
Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis (2011) 3.46
The Pneumonia Etiology Research for Child Health Project: a 21st century childhood pneumonia etiology study. Clin Infect Dis (2012) 3.40
Influenza vaccine effectiveness in the community and the household. Clin Infect Dis (2013) 3.40
Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res (2009) 3.39
Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis (2012) 3.35
Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol (2007) 3.33
Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium. Emerg Infect Dis (2002) 3.32
Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA (2006) 3.31
Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis (2009) 3.26
A case-case comparison of Campylobacter coli and Campylobacter jejuni infection: a tool for generating hypotheses. Emerg Infect Dis (2002) 3.18
Efficacy of zinc in the treatment of severe pneumonia in hospitalized children <2 y old. Am J Clin Nutr (2006) 3.17
Molecular and epidemiologic trends of caliciviruses associated with outbreaks of acute gastroenteritis in the United States, 2000-2004. J Infect Dis (2005) 3.16
Risk factors associated with subclinical human infection with avian influenza A (H5N1) virus--Cambodia, 2006. J Infect Dis (2009) 3.05
Short and long term mortality associated with foodborne bacterial gastrointestinal infections: registry based study. BMJ (2003) 3.03
Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial. J Infect Dis (2010) 3.02
Immunization coverage and risk factors for failure to immunize within the Expanded Programme on Immunization in Kenya after introduction of new Haemophilus influenzae type b and hepatitis b virus antigens. BMC Public Health (2006) 3.01
Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis (2013) 3.00
Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2. PLoS Med (2006) 2.99
Low frequency of poultry-to-human H5NI virus transmission, southern Cambodia, 2005. Emerg Infect Dis (2006) 2.98
Rotavirus vaccines: current prospects and future challenges. Lancet (2006) 2.97
The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis (2004) 2.96
Evaluation of diagnostic tests: dengue. Nat Rev Microbiol (2010) 2.91
Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis (2012) 2.91
Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. Clin Infect Dis (2009) 2.89
The burden of influenza-associated critical illness hospitalizations. Crit Care Med (2014) 2.84
Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respir Viruses (2009) 2.82